ABC101-1 / AbChemBio - LARVOL DELTA

ABChem Bio announces preclinical trial of ‘ABC101-1’ at AACR Breast Cancer Conference [Google translation] (HIT News) - "ABCHEM BIO will present the preclinical data of ABC101-1 in the form of a poster from 5 to 7 p.m. on the 21st at the ‘American Association for Cancer Research (AACR) Breast Cancer Special Conference’ held in San Diego, USA from October 19 to 22. It is scheduled to be announced...ABC101-1 is an ADC that targets HER2-expressing breast cancer cells. It binds specifically to HER2-expressing tumor cells and then induces the death of tumor cells through a microtubule inhibitor, a cytotoxic drug....Detailed information will be released on the 21st of next month."

New molecule • Preclinical • Breast Cancer • Oncology • Solid Tumor